Dr. Karen Hubbard is a Professor of Biology at The City College of New York. She studies cellular senescence using human diploid fibroblasts as a model system. She studies programmed cell death (apoptosis) during aging as well as in cancer. In addition to studying the role of RNA processing during cellular senescence, Dr. Hubbard is investigating the induction of cognitive decline by chemotherapeutic agents.
Dr. Hubbard has a long-standing commitment for training, especially underrepresented minorities. She has mentored many underrepresented minorities students and has served on advisory committees at CCNY to increase underrepresented minorities in the sciences such as the MARC/RISE and TREND programs. She has been a Linkage Fellow for the Minority Affairs Committee of ASCB and was on the Task Force for Minority Affairs Committee of the Gerontological Society of America (GSA). Dr. Hubbard was the PI/PD for the MBRS/SCORE program at CCNY from 2002-2011, a program designed to promote faculty research development at minority serving institutions.
Dr. Hubbard received funding in 2002 for a U56 planning grant to develop collaborative research and training between CCNY and Memorial Sloan-Kettering Cancer Center. In 2008 she received funding as the CCNY PI for a U54 Partnership with MSKCC. The long-term goals of this Partnership are to reduce cancer health disparities.
As a RCMI investigator, she co-leads the RCMI Cancer Area 2 with Dr. Mark Steinberg. The U54 Partnership and CCNY’s RCMI programs have collaborated in recent years to increase the number of research faculty studying cancer-related issues.
[hungryfeed url=”http://www.ncbi.nlm.nih.gov/entrez/eutils/erss.cgi?rss_guid=1rMwxYmtBPsmhR8enm89ekGMbT40JCn7B375BJ7IloUNCbu5OQ” feed_fields=”” link_target=”_blank” truncate_description=”800″ max_items=”1″]More Publications